Nautilus Biotechnology (NAUT) Other Working Capital Changes (2020 - 2026)

Nautilus Biotechnology has disclosed Other Working Capital Changes across 7 years of filings, most recently posting -$1.1 million for Q2 2026.

• In Q2 2026, Other Working Capital Changes rose 8.72% year-over-year to -$1.1 million; the TTM figure through Jun 2026 stood at $817000.0 (up 118.49% YoY), while the FY2025 annual figure was -$4.7 million, down 12.96% from the prior year.
• Other Working Capital Changes came in at -$1.1 million for Q2 2026 at Nautilus Biotechnology, up from -$1.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.2 million in Q4 2025 to a low of -$1.4 million in Q3 2022.
• Average Other Working Capital Changes over 5 years is -$568222.2, with a median of -$1.0 million recorded in 2023.
• Year-over-year, Other Working Capital Changes slumped 241.69% in 2022 and surged 485.67% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$527000.0 in 2022, then tumbled by 91.27% to -$1.0 million in 2023, then fell by 8.04% to -$1.1 million in 2024, then surged by 485.67% to $4.2 million in 2025, then slumped by 125.17% to -$1.1 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$1.1 million in Q2 2026, -$1.1 million in Q1 2026, and $4.2 million in Q4 2025.